STEINBEISSER PROJECT MANAGEMENT UG (HAFTUNGSBESCHRANKT) - DE 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2026-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 8.046.250 250.000 1
2016 0 6.000.000 262.500 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITY OF BIRMINGHAM2
ABBVIE1
ACTELION PHARMACEUTICALS1
AMGEN LIMITED1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA AB1
BAYER PHARMA1
CSL BEHRING1
ELI LILLY AND COMPANY LIMITED1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ERASMUS UNIVERSITEIT ROTTERDAM1
EURETOS BV1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN HEART NETWORK AISBL1
EUROPEAN PATIENTS' FORUM1
F HOFFMANNLA ROCHE1
FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG1
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA FUNDACION INCLIVA1
INSTITUTO TUMORI ""GIOVANNI PAOLO II""1
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS1
ISTITUTO EUROPEO DI ONCOLOGIA1
JANSSEN PHARMACEUTICA NV1
KATHOLIEKE UNIVERSITEIT LEUVEN1
LEIDEN UNIVERSITY1
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE1
MEDICINE MEN BV1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
MINDBYTES1
MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND1
NOVARTIS PHARMA1
PFIZER LIMITED1
ROCHE DIAGNOSTICS NEDERLAND BV1
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT1
TAKEDA DEVELOPMENT CENTRE EUROPE1
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF1
UNIVERSITATSKLINIKUM ERLANGEN1
UNIVERSITEIT UTRECHT1
UNIVERSITY OF NEWCASTLE UPON TYNE1
UPPSALA UNIVERSITET1

Constancy:

Total number of partners: 43
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 43
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Personalised pharmacometabolomic optimisation of treatment for hypertension Hypermarkerparticipant8.046.25012
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033